Clients
| Client Name | Start Year | End Year |
|---|---|---|
| Amicus Therapeutics | 2023 | Current |
| Arvinas | 2023 | Current |
| Merck | 2019 | Current |
| Eli Lilly and Company | 2020 | Current |
| Takeda | 2022 | Current |
| GSK | 2022 | Current |
| AstraZeneca | 2021 | Current |
| Sanofi | 2019 | Current |
| Client Name | Start Year | End Year |
|---|---|---|
| Amicus Therapeutics | 2023 | Current |
| Arvinas | 2023 | Current |
| Merck | 2019 | Current |
| Eli Lilly and Company | 2020 | Current |
| Takeda | 2022 | Current |
| GSK | 2022 | Current |
| AstraZeneca | 2021 | Current |
| Sanofi | 2019 | Current |